Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Mar;39(3):271–276. doi: 10.1111/j.1365-2125.1995.tb04448.x

Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicin.

W W Yeo 1, K S Higgins 1, G Foster 1, P R Jackson 1, L E Ramsay 1
PMCID: PMC1365003  PMID: 7619668

Abstract

1. In nine hypertensive patients with enalapril-induced cough the effect of altering the dose of enalapril on subjective cough and the cough response to inhaled capsaicin was examined in a random single-blind balanced cross-over study. They received three doses of enalapril, each for 3 weeks; the dose at entry (mean 10 mg daily); double this dose (mean 20 mg daily); and half this dose (mean 5 mg daily). 2. The cough response to inhaled capsaicin was also measured in two control groups: hypertensive patients on long-term enalapril treatment with no cough (n = 18), and hypertensive patients taking nifedipine (n = 17). 3. In patients with enalapril-induced cough there were significant dose-responses for enalapril as regards severity of cough (P < 0.05) and night time waking by cough (P < 0.05), but not for frequency of cough. Although the cough was less severe (P < 0.02) and caused less night time waking (P < 0.03) on the lowest dose of enalapril (mean 5 mg daily) it did not disappear completely in any patient. 4. The sensitivity to inhaled capsaicin did not differ significantly on the three doses of enalapril. The relative potency of capsaicin on enalapril 20 mg compared with enalapril 5 mg was 1.0 (95% CI 0.4-2.2). The wide confidence limits indicate that an important dose-dependent shift in capsaicin sensitivity is not excluded. 5. The sensitivity to inhaled capsaicin differed significantly between patients with enalapril-induced cough and both control groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldis W. L. Cromolyn for cough due to angiotensin-converting enzyme inhibitor therapy. Preliminary observations. Chest. 1991 Dec;100(6):1741–1742. doi: 10.1378/chest.100.6.1741c. [DOI] [PubMed] [Google Scholar]
  2. Fletcher A. E., Bulpitt C. J., Hawkins C. M., Havinga T. K., ten Berge B. S., May J. F., Schuurman F. H., van der Veur E., Wesseling H. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens. 1990 May;8(5):463–466. doi: 10.1097/00004872-199005000-00011. [DOI] [PubMed] [Google Scholar]
  3. Foster G., Yeo W. W., Ramsay L. E. Effect of sulindac on the cough reflex of healthy subjects. Br J Clin Pharmacol. 1991 Feb;31(2):207–208. doi: 10.1111/j.1365-2125.1991.tb05518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fuller R. W., Choudry N. B. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. Br Med J (Clin Res Ed) 1987 Oct 24;295(6605):1025–1026. doi: 10.1136/bmj.295.6605.1025-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilchrist N. L., Richards A. M., March R., Nicholls M. G. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study. J Hum Hypertens. 1989 Dec;3(6):451–455. [PubMed] [Google Scholar]
  6. Just P. M. The positive association of cough with angiotensin-converting enzyme inhibitors. Pharmacotherapy. 1989;9(2):82–87. doi: 10.1002/j.1875-9114.1989.tb04107.x. [DOI] [PubMed] [Google Scholar]
  7. McEwan J. R., Choudry N., Street R., Fuller R. W. Change in cough reflex after treatment with enalapril and ramipril. BMJ. 1989 Jul 1;299(6690):13–16. doi: 10.1136/bmj.299.6690.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morice A. H., Lowry R., Brown M. J., Higenbottam T. Angiotensin-converting enzyme and the cough reflex. Lancet. 1987 Nov 14;2(8568):1116–1118. doi: 10.1016/s0140-6736(87)91547-9. [DOI] [PubMed] [Google Scholar]
  9. Os I., Bratland B., Dahlöf B., Gisholt K., Syvertsen J. O., Tretli S. Female sex as an important determinant of lisinopril-induced cough. Lancet. 1992 Feb 8;339(8789):372–372. doi: 10.1016/0140-6736(92)91694-4. [DOI] [PubMed] [Google Scholar]
  10. Pomari C., Turco P., Dal Negro R. Has theophylline a role in the cure and prevention of ACE-inhibitor-related cough? Respiration. 1989;55(2):119–121. doi: 10.1159/000195714. [DOI] [PubMed] [Google Scholar]
  11. Sebastian J. L., McKinney W. P., Kaufman J., Young M. J. Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. Chest. 1991 Jan;99(1):36–39. doi: 10.1378/chest.99.1.36. [DOI] [PubMed] [Google Scholar]
  12. Yeo W. W., Foster G., Ramsay L. E. Prevalence of persistent cough during long-term enalapril treatment: controlled study versus nifedipine. Q J Med. 1991 Sep;80(293):763–770. [PubMed] [Google Scholar]
  13. Yeo W. W., Maclean D., Richardson P. J., Ramsay L. E. Cough and enalapril: assessment by spontaneous reporting and visual analogue scale under double-blind conditions. Br J Clin Pharmacol. 1991 Mar;31(3):356–359. doi: 10.1111/j.1365-2125.1991.tb05544.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yeo W. W., Ramsay L. E. Persistent dry cough with enalapril: incidence depends on method used. J Hum Hypertens. 1990 Oct;4(5):517–520. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES